...
首页> 外文期刊>Clinical and experimental dermatology >Whole exome sequencing identifies a novel pathogenic variation [p.(Gly194valfs*7)] in SLC45A2 SLC45A2 in the homozygous state in multiple members of a family with oculocutaneous albinism in southern India
【24h】

Whole exome sequencing identifies a novel pathogenic variation [p.(Gly194valfs*7)] in SLC45A2 SLC45A2 in the homozygous state in multiple members of a family with oculocutaneous albinism in southern India

机译:整体exome测序鉴定了一种新的致病变异[p。(gly194valfs * 7)]在一个西部南部的多个成员的纯合状态下的SLC45A2 SLC45A2中的纯合状态

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary Deleterious mutations within the SLC45A2 gene, encoding membrane‐associated transporter protein (MATP), are responsible for type 4 oculocutaneous albinism. The cytogenetic location of SLC45A2 is 5p13.2 and it comprises seven exons located over around 40?kb. Its encoded protein, MATP, is 530 amino acids long and has 12 putative transmembrane domains. MATP is synthesized within melanocytes. It is in these cells that melanogenesis takes place and the melanin is contained within specialized organelles called melanosomes. Previous studies have shown that when MATP expression was reduced using small interfering RNA in MNT‐1 melanoma cells, pH was lowered within melanosomes, they became poorly melanized and tyrosinase activity within melanocytes?was also reduced. This type of albinism produces a broad spectrum of phenotypes, ranging from complete absence of melanin to brown hair and brown irides. In the current study, blood was collected from a family in which four members had oculocutaneous albinism, showing a complete absence of melanin in skin, hair and eyes. Screening of the TYR gene using the extracted DNA showed no mutation and therefore whole exome sequencing analysis was performed. A novel deletion mutation c.579delG [p.(Gly194Valfs*7)] in the SLC45A2 gene, predicted to be pathogenic and to result in both frameshift and premature termination of the MATP chain, was identified. These data add to the information pertaining to the mutation spectrum of OCA4.
机译:发明内容SLC45A2基因内的有害突变,编码膜相关的转运蛋白(MATP),对4型血管外形敏感作用负责。 SLC45A2的细胞遗传学位置为5p13.2,它包含七个外显子,位于40ΩkB约40℃。其编码的蛋白质MATP是530氨基酸长,具有12个推定的跨膜结构域。 MATP在黑色细胞内合成。它在这些细胞中,糖化发生,黑素素包含在称为黑色素的专用细胞器内。以前的研究表明,当使用MnT-1黑色素瘤细胞中的小干扰RNA减少MATP表达时,在黑色素内降低pH,它们变得差,黑素细胞内的苯苯胺和酪氨酸酶活性差。也降低了。这种类型的白化病产生了广泛的表型,从完全没有黑素素到棕色毛发和棕色蛋白质。在目前的研究中,从一个家庭收集血液中的血液,其中四名成员具有血管外形,表现出皮肤,头发和眼睛中完全没有黑色素。使用提取的DNA筛选Tyr基因显示出不突变,因此进行全外序测序分析。在SLC45A2基因中,一种新的缺失突变C.579DelG [p。(Gly194Valfs * 7)]预测是致病性的,并导致MATP链的框架和过早终止。这些数据添加到与OCA4的突变谱相关的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号